Advertisement

Influence of the Metabolic Syndrome Versus the Sum of Its Individual Components on Left Ventricular Geometry in Young Adults (from the Bogalusa Heart Study)

      Current preventive cardiology guidelines strongly recommend identification of metabolic syndrome (MS), a constellation of cardiovascular risk factors, in clinical practice. These MS risk factors, individually or in a cluster, adversely alter left ventricular (LV) geometry. However, it is still unclear whether MS predicts risk, above and beyond its individual risk factors, for abnormal LV geometry. This aspect was examined in 830 asymptomatic patients (mean age 37 years, 69% whites, 41% men) as a part of the Bogalusa Heart Study. Patients with MS (as defined by the National Cholesterol Education Program Adult Treatment Panel III) showed adverse levels of echocardiographic parameters compared with patients without MS. With respect to MS components, patients with eccentric hypertrophy (EH) or concentric hypertrophy (CH) showed higher values of MS risk factors compared with patients with normal geometric pattern but no differences were noted between patients with normal and concentric remodeling. Of note, patients with concentric remodeling versus EH showed significantly higher systolic and diastolic blood pressure and fasting glucose levels. A model including only MS strongly predicted risk of EH (odds ratio [OR] 4.16, p <0.0001) and CH (OR 13.6, p <0.0001) compared with normal LV geometry. In a model including only individual MS risk factors, obesity (EH vs normal OR 14.4, p <0.0001), high blood pressure (CH vs normal OR 19.38, p <0.0001), and high fasting glucose levels (CH vs normal OR 4.02, p = 0.001) were significant predictors of abnormal LV geometry. However, the likelihood ratio test and comparisons of C-statistics for models including only individual MS risk factors versus models also including the MS variable were not significant. In conclusion, MS and its individual risk factors were strongly associated with LV geometry. However, MS did not predict risk of abnormal LV geometry independent of its individual components.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • The Bogalusa Heart Study
        20th anniversary symposium.
        Am J Med Sci. 1995; 310: S1-S318
        • Berenson G.S.
        • McMahan C.A.
        • Voors A.W.
        • Webber L.S.
        • Srinivasan S.E.
        • Frank G.C.
        • Foster T.A.
        • Blonde C.V.
        Cardiovascular Risk Factors in Children—The Early Natural History of Atherosclerosis and Essential Hypertension.
        Oxford University Press, New York1980
      1. Berenson G.S. Causation of Cardiovascular Risk Factors in Children: Perspective on Cardiovascular Risk in Early Life. Raven, New York1986: 408
        • Pouliot M.C.
        • Despres J.P.
        • Lemieux S.
        • Moorjani S.
        • Bouchard C.
        • Tremblay A.
        • Nadeau A.
        • Lupien P.J.
        Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women.
        Am J Cardiol. 1994; 73: 460-468
        • Srinivasan S.R.
        • Berenson G.S.
        Serum lipoproteins in children and methods for study.
        in: Lewis L.A. Handbook of Electrophoresis. CRC, Boca Raton, FL1983: 185-204
        • Sahn D.J.
        • DeMaria A.
        • Kisslo J.
        • Weyman A.
        Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.
        Circulation. 1978; 58: 1072-1083
        • Devereux R.B.
        • Alonso D.R.
        • Lutas E.M.
        • Gottlieb G.J.
        • Campo E.
        • Sachs I.
        • Reichek N.
        Echocardiographic assessment of left ventricular geometry hypertrophy: comparison with neconcentric remodelingopsy findings.
        Am J Cardiol. 1986; 57: 450-458
        • de Simone G.
        • Verdecchia P.
        • Schillaci G.
        • Devereux R.B.
        Clinical impact of various geometric models for calculation of echocardiographic left ventricular mass.
        J Hypertens. 1998; 16: 1207-1214
        • de Simone G.
        • Daniels S.P.
        • Devereux R.B.
        • Meyer R.A.
        • Roman M.J.
        • de Divitiis O.
        • Alderman M.H.
        Left ventricular mass and body size in normotensive children and adults: assessment of allometric ealations and impact of overweight.
        J A Coll Cardiol. 1992; 20: 1251-1260
        • de Simone G.
        • Devereux R.B.
        • Daniels S.R.
        • Koren M.J.
        • Alderman M.H.
        • Laragh J.H.
        Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and of their capacity to predict cardiovascular risk.
        J Am Coll Cardiol. 1995; 25: 1056-1062
        • Foppa M.
        • Duncan B.B.
        • Rohde L.
        Echocardiography-based left ventricular mass estimation.
        Cardiovasc Ultrasound. 2005; 3: 17
        • De Simone G.
        • McClelland R.
        • Gottdiener J.S.
        • Celentano A.
        • Kronmal R.A.
        • Gardin J.M.
        Relation of hemodynamics and risk factors to ventricular vascular interactions in the elderly: the Cardiovascular Health Study.
        J Hypertens. 2001; 19: 1893-1903
        • Ganau A.
        • Devereux R.B.
        • Roman M.J.
        • de Simone G.
        • Rickering T.G.
        • Saba P.S.
        • et al.
        Patterns of left ventricular geometry hypertrophy and geometric remodelling in essential hypertension.
        J Am Coll Cardiol. 1992; 19: 1550-1558
      2. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
        JAMA. 2001; 285: 2486-2497
        • Gaudron P.
        • Eilles C.
        • Kugler I.
        • Ertl G.
        Progressive left ventricular dysfunction and remodeling after myocardial infarction potential mechanisms and early predictors.
        Circulation. 1999; 87: 755-763
        • Alpert M.A.
        • Alexander J.K.
        Obesity and Ventricular Function in Man: Systolic Function, the Heart and Lung in Obesity.
        in: Futura, Armonk, NY1998: 77-94
        • Litwin S.E.
        The growing problem of obesity and the heart.
        J Am Coll Cardiol. 2006; 47: 617-619
        • Messerli F.H.
        • Christie J.G.
        • De Carvalh
        • Aristimuno G.G.
        • Suarez D.H.
        • Dreslinski G.R.
        • Frohlich E.R.
        Obesity and essential hypertension hemodynamics, intravascular volume, sodium exconcentric remodelingetion, and plasma renin activity.
        Arch Intern Med. 1981; 141: 81-85
        • Palmieri V.
        • Bella J.N.
        • Arnett D.K.
        • Liu J.E.
        • Oberman A.
        • Schuck M.Y.
        • Kitzman D.W.
        • Hopkins P.N.
        • Morgan D.
        • Rao D.C.
        • Devereux R.B.
        Effect of type II diabetes on left ventricular geometry, and systolic function in hypertensive subjects.
        Circulation. 2001; 103: 102-110
        • Nicolino A.
        • Longobardi G.
        • Furgi G.
        • Rossi M.
        • Zoccolillo N.
        • Ferrara N.
        • Rengo F.
        Left ventricular diastolic filling in diabetes mellitus with and without hypertension.
        Am J Hypertens. 1995; 8: 382-389
        • Bella J.N.
        • Devereux R.B.
        • Roman M.J.
        • Palmieri V.
        • Liu J.E.
        • Paranicas M.
        • Welty T.K.
        • Lee E.T.
        • Fabsitz R.R.
        • Howard B.V.
        Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indian (the Strong Heart Study).
        Am J Cardiol. 2001; 87: 1260-1265
        • Koren M.J.
        • Devereux R.B.
        • Casale P.N.
        • Savage D.D.
        • Laragh J.H.
        Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension.
        Ann Intern Med. 1991; 114: 345-352
        • Verdecchia P.
        • Schillaci G.
        • Borgioni C.
        • Ciucci A.
        • Battistelli M.
        • Bartoccini C.
        • Santucci A.
        • Santucci C.
        • Reboldi G.
        • Porcellati C.
        Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass.
        J Am Coll Cardiol. 1995; 25: 871-878
        • Krumholz H.M.
        • Larson M.
        • Levy D.
        Prognosis of left ventricular geometric patterns in the Framingham Heart Study.
        J Am Coll Cardiol. 2005; 25: 879-884
        • Eguchi K.
        • Kario K.
        • Hoshide S.
        • Ishikawa J.
        • Morinari M.
        • Shimada K.
        Type 2 diabetes is associated with left ventricular concentric remodeling in hypertensive patients.
        Am J Hypertens. 2005; 18: 23-29
        • De Simone G.
        • Palmieri V.
        • Bella J.N.
        • Celentano A.
        • Hong Y.
        • Oberman A.
        • Kitzman D.W.
        • Hopkins P.N.
        • Arnett D.K.
        • Devereux R.B.
        Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study.
        J Hypertens. 2002; 20: 323-331
        • McNell A.M.
        • Rosamond W.D.
        • Girman C.J.
        • Golden S.H.
        • Schmidt M.I.
        • East H.E.
        • Ballantyne C.M.
        • Heiss G.
        The MS and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study.
        Diabetes Care. 2005; 28: 385-390
        • Sattar N.
        • Gaw A.
        • Scherbakova O.
        • Ford I.
        • O'Reilly D.S.
        • Haffner S.M.
        • Isles C.
        • Macfarlane P.W.
        • Packard C.J.
        • Cobbe S.M.
        • Shepherd J.
        MS with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.
        Circulation. 2003; 108 (414–410)
        • Scuteri A.
        • Najjar S.S.
        • Morell C.H.
        • Lakatta E.G.
        The MS in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study.
        Diabetes Care. 2005; 28: 882-887